What Does Wall Street Think About AbCellera Biologics Inc. (ABCL)?

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best strong buy stocks to invest in under $5. AbCellera Biologics Inc. (NASDAQ:ABCL) announced on January 22 that it is set to announce its full-year 2025 financial results on February 24, 2026. Prior to the earnings release, AbCellera Biologics Inc. (NASDAQ:ABCL) received a rating update from Truist Financial on January 13, which reiterated a Buy rating on the stock.

The rating update came after AbCellera Biologics Inc. (NASDAQ:ABCL) announced on January 12 the dosing of the first patients in the Phase 2 portion of its ongoing Phase 1/2 clinical trial for ABCL635. ABCL635 is a potential first-in-class non-hormonal treatment targeted for moderate-to-severe vasomotor symptoms (VMS) associated with menopause.

The company reported that the transition to Phase 2 came after an interim review of the safety, tolerability, and pharmacodynamic data from healthy volunteers from the Phase 1 portion of the study. It added that the Phase 2 portion is a multicenter, randomized, double-blind, placebo-controlled study specifically designed for the evaluation of the efficacy of ABCL635 in bringing down the severity and frequency of VMS in 80 postmenopausal women.

AbCellera Biologics (NASDAQ:ABCL) solves antibody discovery problems by integrating data science, technology, infrastructure, and interdisciplinary teams. It develops and discovers antibody medicines for indications across therapeutic areas, including metabolic and endocrine conditions, cancer, and autoimmune disorders. It boasts technology platforms that unlock drug classes, modalities, and targets, including T-cell engagers, peptide-MHCs, and transmembrane proteins.

While we acknowledge the potential of ABCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.